PTPN22 and hematocrit: In a separate study, significantly elevated levels of DNAm were identified in the promoter region of PTPN22 in young patients with HT, relative to controls; this verified the role of PTPN22 as an epigenetically determined susceptibility gene for thyroid autoimmunity (7).